IFN alpha causes a modest reduction of HIV-1 expression in chronically infe
cted monocytoid U937 cells. However, the ratio between cell-associated and
shed viral p24 antigen is altered, being the cell-associated fraction dose-
dependently enhanced by IFN. Furthermore, a significant decrease of infecti
vity of both cell-associated and shed material is observed. Transmission el
ectron microscopy of IFN-treated cells revealed virus assembly being strong
ly inhibited, with the production of morphologically altered (tear-drop sha
ped) virus particles. Proteolytic processing of gag proteins appeared to be
normal in IFN-treated cultures. However, virions shed from IFN-treated cel
ls showed a markedly reduced incorporation of virus-specific gp120 and cell
-derived ICAM-1 by the virus envelope. Additionally, these particles showed
a significantly decreased ability to become bound to CD4+ target cells, ac
counting for, at least in part, the observed decrease of infectivity. Taken
together the data suggest that, in chronically infected cells, IFN alpha c
an affect late stages of HIV-1 replication, by inhibiting virus assembly an
d release, and by reducing the infectivity of shed virions. The latter effe
ct seems to be due, at least in part, to altered incorporation of surface g
lycoproteins and defective particle formation. The relationship between imp
aired gp120 incorporation and altered morphogenesis of HIV-1 virions is und
er investigation. (C) Societe francaise de biochimie et biologie moleculair
e/Elsevier, Paris.